0001209191-23-007547.txt : 20230207 0001209191-23-007547.hdr.sgml : 20230207 20230207164410 ACCESSION NUMBER: 0001209191-23-007547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20230203 FILED AS OF DATE: 20230207 DATE AS OF CHANGE: 20230207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Molineaux Susan CENTRAL INDEX KEY: 0001553389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 23595682 MAIL ADDRESS: STREET 1: C/O CALITHERA BIOSCIENCES, INC. STREET 2: 343 OYSTER POINT BLVD., SUITE 200 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING A, SUITE 510 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 128 SPRING STREET STREET 2: BUILDING A, SUITE 510 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-02-03 0 0001662244 Cyteir Therapeutics, Inc. CYT 0001553389 Molineaux Susan C/O CYTEIR THERAPEUTICS, INC. 128 SPRING ST, BUILDING A, SUITE 510 LEXINGTON MA 02421 1 0 0 0 Stock Option (Right to Buy) 1.69 2023-02-03 4 A 0 14150 0.00 A 2033-02-03 Common Stock 14150 14150 D The shares of common stock underlying this stock option award vest in full on February 3, 2024, subject to the Reporting Person's continued service to the board of directors of the Company through the applicable vesting date. Exhibit List: Exhibit 24 - Power of Attorney /s/ Adam M. Veness, as attorney-in-fact for Susan Molineaux 2023-02-07 EX-24 2 poa.txt POA DOCUMENT SUBSTITUTE POWER OF ATTORNEY Pursuant to the Limited Power of Attorney of Susan Molineaux, Ph.D. (the "Power of Attorney"), dated May 24, 2021 and filed with the Securities and Exchange Commission, the undersigned has been constituted and appointed true and lawful attorney-in-fact, with full power of substitution, to, on behalf of Dr. Molineaux: (1) prepare, execute in the undersigned's name and on the undersigned's behalf, and submit to the U.S. Securities and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any other documents necessary or appropriate to obtain codes and passwords enabling the undersigned to make electronic filings with the SEC of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, or any rule or regulation of the SEC; (2) execute for and on behalf of the undersigned, in the undersigned's capacity as officer and/or director of Cyteir Therapeutics, Inc. (the "Company"), Forms 3, 4, 5 and any Schedules 13D or 13G in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder; (3) do and perform any and all acts for and on behalf of the undersigned that may be necessary or desirable to complete and execute any such Form 3, 4, or 5 or Schedule 13D or 13G, complete and execute any amendment or amendments thereto, and timely file such form with the SEC and any stock exchange or similar authority; and (4) take any other action of any type whatsoever in connection with the foregoing that, in the opinion of each such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by each such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as each such attorney-in-fact may approve in each such attorney-in-fact's discretion. Pursuant to the powers granted to the undersigned in the Power of Attorney, the undersigned hereby constitutes and appoints Adam Veness as a substitute to the undersigned attorney-in-fact, with full power of substitution, and with full power and authority to do and perform every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of the rights and powers granted to the undersigned in said Power of Attorney. For the avoidance of doubt, the foregoing appointment shall not serve as a revocation of the powers granted to the undersigned himself in the Power of Attorney. This Substitute Power of Attorney shall remain in full force and effect unless and until revoked by the undersigned. [Remainder of page intentionally left blank] IN WITNESS WHEREOF, the undersigned has caused this Substitute Power of Attorney to be executed as of this 7th day of February, 2023. /s/ David Gaiero ------------------- David Gaiero